{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:02:47Z","timestamp":1781708567450,"version":"3.54.5"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Hum. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dopamine agonist withdrawal syndrome (DAWS) is a severe condition reported primarily in Parkinson's disease (PD) but increasingly recognized in restless legs syndrome (RLS). While DAWS is classically associated with high-dose dopamine agonists (DAs) in Parkinson's disease, it has also been reported in RLS patients treated with low-dose therapy (\u2264 0.75 mg pramipexole equivalent), although such cases remain rare. While direct evidence is lacking, psychological and relational stressors, in conjunction with prior medication adjustments, could plausibly modulate DAWS severity through a mechanism akin to kindling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We describe the case of a 51-year-old male who developed severe DAWS after withdrawing from low-dose pramipexole (0.26 mg) prescribed for RLS. A 6-month venlafaxine taper, completed 2 weeks before DA tapering, may have increased neurochemical vulnerability. Initial dose reduction caused akathisia, tremors, panic attacks, RLS worsening, and depressive symptoms. After brief reinstatement, abrupt cessation triggered painful electric-like sensations in the lower back and emotional collapse. The patient was transitioned to rotigotine (2 mg\/day), together with other psychotropic medications, which provided partial and temporary relief. Symptoms relapsed during tapering, with marked worsening occurring in parallel with episodes of severe relational stress within a close personal connection. Clinical assessments explored these interactions as potential psychological stressors, as reported by the patient. Given the temporal association between these stressors and symptom relapses, relational factors may have contributed to the severity and recurrence of DAWS episodes. At 13 months after complete DA discontinuation, the patient has regained nearly full functionality, although episodes of marked fatigue and significant bedtime RLS persists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and conclusion<\/jats:title>\n                    <jats:p>This case illustrates that DAWS can occur in RLS patients even at low DA doses, with atypical symptoms possibly involving autonomic and central sensitization. Relational stress may significantly exacerbate symptom severity, potentially leading to profound neurological destabilization through mechanisms such as cross-system hypersensitivity or a kindling-like process, as suggested by existing literature. This factor may need to be systematically assessed in DAWS management. As a rare patient-authored account, this report contributes to the understanding of DAWS in non-PD populations and highlights the need for longitudinal research to guide safer withdrawal protocols and integrated care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnhum.2025.1613710","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T08:15:44Z","timestamp":1768205744000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["RETRACTED: Case Report: Prolonged DAWS in an RLS patient under severe relational stress"],"prefix":"10.3389","volume":"19","author":[{"given":"Micha\u00ebl","family":"Gillon","sequence":"first","affiliation":[{"name":"Exoplanets in Transit: Identification and Characterization (ExoTIC) Research Group, Astrobiology Research Unit, University of Li\u00e8ge","place":["Li\u00e8ge, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome\/willis-ekbom disease diagnostic criteria: updated international restless legs syndrome study group (irlssg) consensus criteria\u2014history, rationale, description, and significance","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med"},{"key":"B2","first-page":"25","article-title":"Kindling in alcohol withdrawal","volume":"22","author":"Becker","year":"1998","journal-title":"Alcohol Health Res. World"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.parkreldis.2012.06.006","article-title":"Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome","volume":"19","author":"Dorfman","year":"2013","journal-title":"Parkinson. Relat. Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.sleep.2013.05.016","article-title":"The long-term treatment of restless legs syndrome\/willis-ekbom disease: evidence-based guidelines and clinical consensus best practice guidance","volume":"14","author":"Garcia-Borreguero","year":"2013","journal-title":"Sleep Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0014-4886(69)90128-9","article-title":"A permanent change in brain function resulting from daily electrical stimulation","volume":"25","author":"Goddard","year":"1969","journal-title":"Exp. Neurol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/j.2040-4603.2014.tb00557.x","article-title":"Dysautonomia in parkinson disease","volume":"4","author":"Goldstein","year":"2014","journal-title":"Comprehens. Physiol"},{"key":"B8","unstructured":"Healthunlocked\n          \n          2025"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/nn.4114","article-title":"Stress effects on the neural substrates of motivated behavior","volume":"18","author":"Hollon","year":"2015","journal-title":"Nat. Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","article-title":"The neural basis of addiction: a pathology of motivation and choice","volume":"162","author":"Kalivas","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.smrv.2017.06.002","article-title":"The influence of antidepressants on restless legs syndrome and periodic limb movements: a systematic review","volume":"38","author":"Kolla","year":"2018","journal-title":"Sleep Med. Rev"},{"key":"B12","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0149-7634(94)00019-W","article-title":"Dopamine receptor supersensitivity","volume":"19","author":"Kostrzewa","year":"1995","journal-title":"Neurosci. Biobeh. Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.31887\/DCNS.2006.8.4\/bmcewen","article-title":"Protective and damaging effects of stress mediators: central role of the brain","volume":"8","author":"McEwen","year":"2006","journal-title":"Dial. Clin. Neurosci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.31887\/DCNS.2013.15.4\/enestler","article-title":"Cellular basis of memory for addiction","volume":"15","author":"Nestler","year":"2013","journal-title":"Dial. Clin. Neurosci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40266-013-0090-z","article-title":"Dopamine agonist withdrawal syndrome: implications for patient care","volume":"30","author":"Nirenberg","year":"2013","journal-title":"Drugs Aging"},{"key":"B17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.amjmed.2018.09.027","article-title":"Autonomic disorders","volume":"132","author":"Novak","year":"2019","journal-title":"Am. J. Med"},{"key":"B18","doi-asserted-by":"publisher","author":"Os\u00f3rio de Oliveira","year":"2016","DOI":"10.1002\/14651858.CD006941.pub2"},{"key":"B19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-clinpsy-050212-185606","article-title":"Depression, stress, and anhedonia: toward a synthesis of self-report and neurobiological measures","volume":"10","author":"Pizzagalli","year":"2014","journal-title":"Annu. Rev. Clin. Psychol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.neubiorev.2007.04.003","article-title":"Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena","volume":"31","author":"Post","year":"2007","journal-title":"Neurosci. Biobehav. Rev"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1523\/JNEUROSCI.3422-03.2004","article-title":"Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care","volume":"24","author":"Pruessner","year":"2004","journal-title":"J. Neurosci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/archneurol.2009.294","article-title":"Dopamine agonist withdrawal syndrome in parkinson disease","volume":"67","author":"Rabinak","year":"2010","journal-title":"Arch. Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1038\/npp.2010.134","article-title":"Episodic withdrawal promotes psychomotor sensitization to morphine","volume":"35","author":"Rothwell","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s10072-014-1996-x","article-title":"Dopamine agonist withdrawal syndrome in a patient with restless legs syndrome without impulse control disorder or drug abuse","volume":"36","author":"Shimo","year":"2015","journal-title":"Neurol. Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.2174\/1570159X19666210517115706","article-title":"Pharmacological and non-pharmacological treatments of sleep disorders in parkinson's disease","volume":"19","author":"Taximaimaiti","year":"2021","journal-title":"Curr. Neuropharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1212\/WNL.0000000000002542","article-title":"Restless legs syndrome associated with major diseases: a systematic review and new concept","volume":"86","author":"Trenkwalder","year":"2016","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1474-4422(18)30311-9","article-title":"Comorbidities, treatment, and pathophysiology in restless legs syndrome","volume":"17","author":"Trenkwalder","year":"2018","journal-title":"Lancet Neurol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"682448","DOI":"10.3389\/fneur.2021.682448","article-title":"Jidong restless legs syndrome cohort study: objectives, design, and baseline screening","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Neurol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1212\/WNL.0000000000003388","article-title":"Practice guideline summary: treatment of restless legs syndrome in adults: report of the guideline development, dissemination, and implementation subcommittee of the american academy of neurology","volume":"87","author":"Winkelman","year":"2016","journal-title":"Neurology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e1520","DOI":"10.1212\/WNL.0000000000206855","article-title":"Long-term safety, dose stability, and efficacy of opioids for patients with restless legs syndrome in the national rls opioid registry","volume":"100","author":"Winkelman","year":"2023","journal-title":"Neurology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.2147\/IJGM.S544680","article-title":"Unraveling restless legs syndrome: a comprehensive review of current research and future directions","volume":"18","author":"Xu","year":"2025","journal-title":"Int. J. Gen. Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jns.2016.12.070","article-title":"Dopamine agonist withdrawal syndrome: a comprehensive review","volume":"374","author":"Yu","year":"2017","journal-title":"J. Neurol. Sci"},{"key":"B33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41531-020-00126-x","article-title":"Multiple comorbid sleep disorders adversely affect quality of life in parkinson's disease patients","volume":"6","author":"Zhang","year":"2020","journal-title":"NPJ. Parkinson's Dis"}],"updated-by":[{"DOI":"10.3389\/fnhum.2026.1909710","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000}}],"container-title":["Frontiers in Human Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnhum.2025.1613710\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:35:20Z","timestamp":1781706920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnhum.2025.1613710\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":33,"alternative-id":["10.3389\/fnhum.2025.1613710"],"URL":"https:\/\/doi.org\/10.3389\/fnhum.2025.1613710","relation":{},"ISSN":["1662-5161"],"issn-type":[{"value":"1662-5161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1613710"}}